Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial
- Type
- Retraction
- Notice date
- 3/2/2024 0:00
- Journal
- Journal of Medical Virology
- Publisher
- Wiley
- Notice DOI
- 10.1002/jmv.29509
- Original paper DOI
- 10.1002/jmv.28097
Reasons
- Concerns/Issues about Data
- Conflict of Interest
- Investigation by Journal/Publisher
- Investigation by Third Party
- Objections by Author(s)
- Unreliable Results and/or Conclusions